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Keratinocytes are known to produce, store, and release 
IL-laand therefore we suspected that the DNA-me-
diated cell transfection procedure Ulay release the 
stored IL-la from keratinocytes into the medium. 
Using enzyme-linked immunosorbent assay, we deter-
mined the IL-la concentration in culture supernatants 
during keratinocyte transfection. The following trans-
fection methods were compared: lipofection with li-
pofectACE and lipofectAMINE (GIBCO), Ca3(PO.h 
co-precipitation, and polybrene-dimethylsulfoxide 
(DMSO). The supernatants were collected immedi-
ately prior to transfection, after 5-h incubation with 
lipofectin or Ca3(PO .h, and 24 and 48 h after transfec-
T ransfection of keratinocytes by several methods, in-cluding lipofection, Ca3(P04h and Sr3(P04h co-pre-cipitation, and the use of polycations such as poly-brene [1] has been used to study modulators of gene expression and differentiation, such as Ca++, reti-
noids, and tumor promoters, and to study regulation by growth 
factors and cytokines [2]. Epidermal keratinocytes both produce and 
respond to growth factors and cytokines [3]; however, there has 
been no analysis of growth factors or cytokines released during and 
after transfection, which may affect the results of transfection. For 
example, keratinocytes are known to produce and store interleukin 
1a (IL-1a) [4] and we suspected that the transfection procedures 
themselves may release the stored IL-1a into the medium. There-
fore we used an enzyme-linked immunosorbent assay (ELISA) to 
investigate the release of IL-1a into the supernatant during kerati-
nocyte transfection. Four transfection methods-lipofection with 
lipofectACE and lipofectAMINE, Ca3(P04h co-precipitation, and 
polybrene-dimethylsulfoxide (DMSO) - mediated transfection-
were examined. The results of our studies indicate that a substantial 
amount ofIL-1a is released into the medium during and after kerat-
inocyte transfection. 
The release of IL-la is particularly important because of the 
central role that the cytokine plays in the a~ti~ation ofker~tinocytes 
[5] . Apparently, the release ofIL-la upon 1l1JUry of keratmocytes is 
the triggering event that initiates inflammatory processes and kerat-
inocyte activation in general [5,6]. The multifaceted effect of IL-l 
include stimulation of growth, induction of additional growth fac-
tors, and activation of T cells [7 - 9]. IL-1 specifically induces syn-
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tion. In the polybrene-DMSO method, the supernatant 
was also collected immediately before and after 
DMSO shock. LipofectAMINE caused the highest re-
lease of IL-la, whereas the lipofectACE and poly-
brene-DMSO mediated transfection with confluent 
cells released the least. The other two methods released 
intermediate levels of IL-la. Our data indicate that a 
substantial amount ofIL-la is released during the ke-
ratinocyte transfection procedure, which can affect 
the results of transfection in studies of gene expression. 
Key words: cytokines/DNA/keratin/promoter/wound heal-
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thesis of acute phase response proteins, protooncoproteins, and ex-
tracellular proteases [10-12]. 
MATERIALS AND METHODS 
Cell Growth and Transfection Primary human foreskin epidermal ker-
atinocytes (HEK) were established in culture using 3T3 feeder cells, as 
described [2]. Keratinocytes were grown without feeder cells in defined 
serum-free keratinocyte medium supplemented with epidermal growth fac-
tor and bovine pituitary extract (keratinocyte-SFM, GlBCO) and trans-
fected at 80-100% conBuency. LipofectACE and lipofectAMINE were 
used as described by the manufacturer (GlBCO). Transfection using 
Ca)(P04h co-precipitation, and polybrene with DMSO shock were per-
formed as previously described [1]. Each transfection contained 10 Jig/dish 
K#14 gene and 3 Jig/dish RSVZ gene. 
Collection of Supernatant Fractions At indicated timepoints the entire 
medium supernatants were collected and saved for determination of IL-1a 
concentration. In the polybrene-DMSO-mediated transfections, superna-
tants were collected just before transfection, immediately before and imme-
diately after DMSO shock, and 24 and 48 h after transfection. In lipofection 
and Ca)(P04h co-precipitation, the supernatants were collected immedi-
ately before transfection, 5 h after incubation with lipofectACE, Lipofect-
AMINE, or Ca)(P04h. and 24 and 48 h after transfection. As a control, 
untransfected keratinocyte cultures were prepared and the supernatants were 
collected at the times corresponding to those of transfected cultures. 
ELISA IL-1a concentration in the supernatant was measured utilizing an 
IL-1a ELISA kit purchased from Endogen Inc. Briefly, 96-welJ plates pre-
coated with anti-IL-1a antibody were incubated overnight with samples 
and standards, washed five times, incubated with anti - IL-1a conjugate for 4 
h, washed five times again, then developed with chromogenic substrate in 
the dark. The optical density of each well was measured with a spectropho-
tometer using a 405-nm filter. These experiments were repeated three times, 
always using duplicate plates. DNA was included in all transfections. 
Chloramphenicol Acetyl Transferase and p-Galactosidase Assays 
Duplicate plates of each transfection procedure were transfected at the same 
time. After the 48-h timepoint supernatants were removed, the cells were 
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Figure 1. IL-la levels were determined at indicated tilnepoints 
using ELISA. The two points with arrows indicate that these values could 
not be determined because DMSO interferes with ELISA. The DMSO 
shock was performed 5 hours after addition of polybrene. The 24-h time-
point in the LipofectAMINE experiment showed an extremely high con-
centration of IL-la. above the linear range of ELISA. Note that in the 
untransfected cells (control) the level oflL-la is below the level of ELISA 
sensitivity. 
harvested by scraping. and the CAT and p-gal activities were measured in the 
way previously described [1). 
Cell Counting Duplicate plates for each transfection procedure were 
transfected at the same time. and the cell numbers were counted 48 h after 
transfection. The medium of one of the two plates was aspirated. the cells 
were washed with phosphate-buffered saline (PBS) three times. then tryp-
sinized and counted with hemocytometer under the microscope (N1). The 
other plate was trypsinized without aspirating the medium. and the cells 
were counted in the same way (N2). Dead cells were calculated by subtract-
ing N1 from N2. For the cell counting experiments DNA was included in 
the transfection. but the released IL-1 and transfection efficiency were not 
determined. 
DNA Constructs For the experiments we used K14CAT and pRSVZ 
plasmids described before [1). In addition we used IL8CAT construct. a gift 
from I. Vilcek. which contains the human IL-8 gene promoter driving CAT. 
This construct was shown to be responsive to !L-la [13) . 
RESULTS 
Considerable concentrations ofIL-la were detected in the superna-
tants of keratinocyte cultures during and after transfection (Fig 1). 
LipofectAMINE showed the highest concentration ofIL-la (over 
2600 pg/ml after 24 h) and lipofectACE and polybrene-DMSO-
mediated transfection of confluent cells showed the lowest (200 
pg/ml). Ca3(P04h co-precipitation and polybrene-DMSO me-
diated transfections of subconfluent cells showed intermediate con-
centrations. There were no feeder cells present when we performed 
the transfection and therefore the released IL-la derives from the 
keratinocytes. The release of IL-la is relatively long lasting and 
continues for at least 48 h (Fig 1). 
Consistent with these results, LipofectAMINE caused the most 
severe and prolonged damage to keratinocytes. In the period from 5 
to 24 h after transfection the accumulated IL-la levels climbed 
above the linear range of the assay. During the second day after 
transfection the release ofIL-la subsided somewhat although it was 
still higher than in any other transfection protocol. 
Similarly, Ca3(P04h co-precipitation resulted in prolonged high 
concentration of released IL-la after 5 and 24 h, which indicates 
that the transfection procedure caused severe damage to keratino-
cytes. 
In polybrene-DMSO transfections of subconfluent cells, super-
natant IL-la increased at 24, and especially 48 h, after DMSO 
treatment, which suggests that DMSO shock causes long-lasting 
damage to keratinocytes. On the other hand, the same procedure 
with confluent cells caused release of one-third as much IL-la, 
which suggests that the damage caused to confluent cells is much 
less than that to subconfluent cells. Although in polybrene-
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Figure 2. Supernatant IL-la levels were plotted against the numbers 
of dead cells in different transfection methods. Because most of the 
cells were already dead in Ca)(PO.h co-precipitation at 24 h after transfec-
tion, when the medium was changed. it was excluded from this figure. 
DMSO - mediated transfection we could detect significant concen-
trations ofIL-la only 24 and 48 h after transfection, we believe that 
there was also a significant release of IL-la in the supernatant im-
mediately after DMSO shock, because DMSO causes severe, albeit 
transient, damage to the cell membrane. However, the amount of 
IL-la released in this step could not be accurately determined be-
cause DMSO significantly interferes with ELISA procedure (M. 
Komine, data not shown). 
The mildest of the transfection procedures was the one using 
lipofectACE. The concentration of released IL-la reached 140 pg/ 
ml (Fig 1). It should be noted, however, that these low levels of 
released IL-la are clearly due to the transfection procedure, because 
in untransfected cultures we could not detect any release of IL-l a. 
We hypothesized that the IL-la release is due to the damage 
inflicted upon the cells. If so, then the levels of IL-la released 
should be proportional to the cell death caused by the transfection. 
Therefore we determined the number of dead cells resulting from 
the transfection (Fig 2). Indeed, the concentration ofIL-la in the 
supernatant was proportional to the number of dead cells. In 
Ca3(PO 4h co-precipitation, most of the cells were already dead at 24 
h. Whereas polybrene-DMSO-mediated transfection with con-
fluent cells released 112 pg/ml of IL-la in supernatant, the same 
procedure with subconfluent cells released 340 pg/ml of IL-la, 
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Figure 3. The concentration ofIL-1a released during the transfec-
tion procedure can effect regulation of gene expression. IL-8-CAT 
gene was transfected with the polybrene-DMSO method and stimulated 
with low concentration ofIL-1a. the cells harvested, and the CAT assay was 
performed. IL-8-CAT activity was induced with these low concentrations 
of IL-1a. 
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Figure 4. Comparison of the efficiency of transfection. The CAT and 
p-gal activities obtained with different transfectlon methods were deter-
mined. Polybrene-DMSO-mediated transfection with confluent cells was 
the most efficient method of transfection. 
which shows a proportional correlation with the numbers of dead 
cells (3.2 X lOS. and 9.1 X 105 , respectively, Fig 2). 
To determine whether the levels of IL-ta released are high 
enough to affect the cells, we transfected keratinocytes with a DNA 
construct containing the human IL-8 gene promoter. CAT assays 
with the IL-8 - CAT gene stimulated with a low concentration of 
IL-la show that even the low concentrations of IL-la released by 
keratinocytes during transfection are able to cause induction ofIL-8 
promotor activity (Fig 3). IL-ta by itself has no effect on the 
efficiency of transfection because the levels of p-gal remained un-
changed even at high concentrations (data not shown). Concentra-
tions of 0.5 ng/ml and 1.0 ng/ml of IL-la caused a measurable 
increase ofIL-8-CAT activities compared to the basal level. 
CAT and p-gal activities measured after the various transfection 
procedures indicate that polybrene-DMSO - mediated transfection 
with confluent cells is the most efficient way of introducing DNA 
into keratinocytes. The Ca3(P04h co-precipitation is the least effi-
cierit way (Fig 4). Polybrene-DMSO-mediated transfection with 
subconfluent cells seems to be as efficient as transfection with lipo-
fectACE. 
DISCUSSION 
IL-ta, which is produced and stored in keratinocytes, is known to 
be released when keratinocytes are damaged by various incidents, 
such as mechanical injury, ultraviolet irradiation, and other inflam-
matory processes [6,9]. It is also known to have a mitogenic effect on 
keratinocytes, and to stimulate production of cytokines, such as 
IL-t, IL-6, granulocyte/macrophage colony-stimulating factor, 
and IL-8 [5,7 - 9]. These cytokines are thought to initiate the pro-
duction of an inflammatory infiltrate and to activate fibroblasts to 
proliferate and produce collagen in wound healing [t4]. It is there-
fore believed that the release ofIL-la by damaged keratinocytes is 
the initial trigger of the inflammatory process. 
Because the transfection procedure severely damages keratino-
cytes, we suspected that IL-ta may be released during transfection 
as well. Indeed, our data provide the evidence that keratinocytes 
release IL-ta during transfection, which may modify the results of 
transfection. We have compared different methods of transfection 
and found that different amounts of IL-la were released. The level 
of the release seems to be correlated with the extent of cell damage. 
The least amount ofIL-la is released when LipofectACE is used, or 
when confluent cells are transfected using polybrene/DMSO. 
These two procedures cause the least damage on keratinocytes. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Because IL-ta has profound effects on keratinocytes, it is impor-
tant to know that this cytokine is released during transfection. This 
becomes especially important when one studies the effects of cyto-
kines or growth factors on regulation of transcription of genes in 
keratinocytes. We have been investigating the effects of IL-la on 
gene transcription and the results in Fig 3 are evidence that the 
IL-la released from keratinocytes during the transfection proce-
dure affects the pathways regulated by IL-la. 
Keratinocytes are also known to produce several other cytokines, 
including IL-8, IL-6, tumor necrosis factora, and transforming 
growth factoea, which are also induced by IL-ta [7 -9,15,16]. It is 
possible that these cytokines are also released or induced during 
keratinocyte transfection, which can affect experimental results. 
Our results should serve as a warning for those who study the effects 
of cytokines and growth factors by transfecting keratinocytes. They 
suggest the use of LipofectACE, a mild procedure that releases the 
least IL-la. On the other hand, the use of LipofectAMINE may be 
the method of choice for a deliberate release of IL-Ia. 
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